OPTIMIZATION OF BIOEQUIVALENCE PROGRAMS AND PHARMACOECONOMIC DECISION-MAKING FOR GENERIC METFORMIN HYDROCHLORIDE IMMEDIATE-RELEASE TABLETS: A REGULATORY BIOPHARMACEUTICS FRAMEWORK. Journal of Multidisciplinary Sciences and Innovations, [S. l.], v. 5, n. 6, p. 719–726, 2026. DOI: 10.55640/. Disponível em: https://ijmri.de/index.php/jmsi/article/view/8050. Acesso em: 17 jun. 2026.